Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Surviving Wednesday's Wild Ride in Healthcare and Biotech
Seeking Alpha
Thursday, October 1, 2009 - 10:40am
tags:
biotech, Caraco, Senomyx, Sucampo, Orexigen, Vivus, Sequenom, Biocryst
Glaxo Kidney Cancer Drug Has Liver Risk, FDA Says
Bloomberg
Thursday, October 1, 2009 - 9:43am
tags:
GSK, kidney cancer, pazopanib
AstraZeneca on Suicide Mission in Drug Pricing Litigation
BNET Pharma
Thursday, October 1, 2009 - 9:41am
tags:
drug pricing, AstraZeneca, Zoladex, Medicare
BioCryst Updates the Obvious
TheStreet.com
Thursday, October 1, 2009 - 9:40am
tags:
Biocryst, Flu, peramivir
Abbott Records a 35% Reduction in Oil and Gas Usage
Seeking Alpha
Thursday, October 1, 2009 - 9:38am
tags:
Abbott Laboratories, environmental concerns
Sanofi expands R&D pipeline with two biotech deals
Reuters
Thursday, October 1, 2009 - 9:18am
tags:
Sanofi, R&D, Fovea, M&A, Merrimack Pharmaceuticals
Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Yahoo/AP
Thursday, October 1, 2009 - 9:13am
tags:
M&A, Facet Biotech, Biogen Idec
Biogen Idec options trading soars
Boston Globe, MA
Thursday, October 1, 2009 - 9:10am
tags:
Biogen Idec, M&A, JNJ
Eli Lilly Still Range-Bound Despite a Bet Otherwise
Seeking Alpha
Thursday, October 1, 2009 - 9:01am
tags:
Eli Lilly
Sanofi-Aventis Signs Deal to Buy France's Fovea
Smart Money
Thursday, October 1, 2009 - 8:57am
tags:
Sanofi, France, M&A, Fovea
China Requires One Divestiture for Pfizer / Wyeth Merger
Seeking Alpha
Thursday, October 1, 2009 - 8:56am
tags:
China, M&A, Pfizer, Wyeth
The Novartis-AstraZeneca Deal Worst-Case Scenario
BNET Pharma
Thursday, October 1, 2009 - 7:35am
tags:
Novartis, AstraZeneca, M&A
Vertex Pharma sees wider 2009 loss, raises cash by issuing debt and selling telaprevir rights
Yahoo/AP
Thursday, October 1, 2009 - 7:34am
tags:
Vertex Pharmaceuticals, JNJ, Telaprevir
J&J Tries to Buy Itself a Pipeline
Businessweek
Thursday, October 1, 2009 - 7:33am
tags:
JNJ, Cougar Biotechnology, M&A, Elan, Crucell
Doctors Prescribe Caution With Sanofi Insulin’s Ties to Cancer
Bloomberg
Thursday, October 1, 2009 - 7:32am
tags:
Sanofi, insulin, Lantus
Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Bloomberg
Thursday, October 1, 2009 - 7:30am
tags:
diabetes, AstraZeneca, Dapagliflozin, Bristol-Myers Squibb
New Pharma Guidelines: No Ghostwriting, More Public Info
WSJ Online
Wednesday, September 30, 2009 - 6:08pm
tags:
pharma guidelines, Ghostwriting, PhRMA
More Questions Than Answers From Elan
Motley Fool
Wednesday, September 30, 2009 - 6:07pm
tags:
Elan, Biogen Idec, Tysabri, MS, multiple sclerosis
Stem Cell Summit Can't Excite Investors
Yahoo/Indie Research
Wednesday, September 30, 2009 - 3:52pm
tags:
stem cells, Neuralstem, Aastrom, Orexigen, Cytori, Osiris
Discovery Labs: Pump Up The Volume
TheStreet.com
Wednesday, September 30, 2009 - 3:51pm
tags:
Discovery Labs, FDA, Surfaxin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.